Literature DB >> 16723453

UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling.

Nick Di Girolamo1, Denis Wakefield, Minas T Coroneo.   

Abstract

PURPOSE: Pterygium is a proliferative, inflammatory, and invasive ocular surface disease associated with excessive ultraviolet (UV) exposure. This investigation was conducted to identify UV activated signaling pathways in pterygium epithelial cells (PECs) that mediate cytokine and growth factor production and to determine whether these pathways are sensitive to blockade by anti-inflammatory agents such as retinoic acid (RA) and interferon (IFN)-alpha.
METHODS: PECs were pretreated with or without inhibitors of the ERK1/2, JNK, and p38 (PD98059, SB202190, and SB203580, respectively) mitogen-activated protein kinases (MAPK) or with inhibitors of the tyrosine kinase activity of epidermal growth factor receptor (EGFR; PD153035) and platelet-derived growth factor (PDGF; AG1295); exposed to UVB (20 mJ/cm2); and then further treated with the same inhibitors. Media were harvested and analyzed by ELISA for interleukin (IL)-6, IL-8, and vascular endothelial growth factor (VEGF). Cytokine mRNA was assessed by reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: Inhibitors of ERK1/2, JNK, and p38 MAPKs significantly abolished the UVB-mediated increase in IL-6, IL-8, and VEGF. PD153035 reduced IL-8, AG1295 repressed IL-6, and both inhibitors partially downregulated VEGF production in UV-exposed PECs. RA and IFN-alpha dose dependently abrogated IL-6 and IL-8 but had no effect on VEGF expression after UV exposure.
CONCLUSIONS: The results have identified a stress-induced intracellular pathway and potential cell-surface transmitters that may be relevant to pterygium development. Moreover, two anti-inflammatory/antiangiogenic agents were identified that reduced cytokine production in the study model. Topical application of these drugs may benefit patients with pterygia, potentially reducing the necessity for surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723453     DOI: 10.1167/iovs.05-1130

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  43 in total

1.  Topical dobesilate eye drops for ophthalmic primary pterygium.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-03-08

2.  Inhibitory effect of PPARγ agonist on the proliferation of human pterygium fibroblasts.

Authors:  Yuan Zou; Mingchang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

3.  Ophthalmic pterygium: a stem cell disorder with premalignant features.

Authors:  Jeanie Chui; Minas T Coroneo; Lien T Tat; Roger Crouch; Denis Wakefield; Nick Di Girolamo
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

5.  Inhibition effect of curcumin on UVB-induced secretion of pro-inflammatory cytokines from corneal limbus epithelial cells.

Authors:  Shih-Chun Chao; Dan-Ning Hu; Joan Roberts; Xilun Shen; Chia-Yi Lee; Chan-Wei Nien; Hung-Yu Lin
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

6.  The Key Role of VEGF in the Cross Talk between Pterygium and Dry Eye and Its Clinical Significance.

Authors:  Chang Liu; Yiyue Song; Xiaoran Wang; Zhaoguang Lai; Chaoyang Li; Pengxia Wan; Nuo Xu; Danping Huang; Yizhi Liu; Zhichong Wang
Journal:  Ophthalmic Res       Date:  2020-01-10       Impact factor: 2.892

Review 7.  The role of heredity in pterygium development.

Authors:  Peter Anguria; James Kitinya; Sam Ntuli; Trevor Carmichael
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

8.  The expression of vascular endothelial growth factor in pterygium tissue of atopic patients.

Authors:  Hamid Gharaee; Mohammad Reza Shayegan; Mohammad Reza Khakzad; Sina Kianoush; A-Reza Varasteh; Mojtaba Sankian; Mojtaba Meshkat
Journal:  Int Ophthalmol       Date:  2014-10-26       Impact factor: 2.031

9.  Risk factors for pterygium recurrence after limbal-conjunctival autografting: a retrospective, single-centre investigation.

Authors:  Naser Samadi Aidenloo; Qader Motarjemizadeh; Maryam Heidarpanah
Journal:  Jpn J Ophthalmol       Date:  2018-03-16       Impact factor: 2.447

10.  Calcium-binding S100 protein expression in pterygium.

Authors:  Andri K Riau; Tina T Wong; Roger W Beuerman; Louis Tong
Journal:  Mol Vis       Date:  2009-02-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.